From:
DEPARTMENT of HEALTH and HUMAN SERVICES
Fiscal Year 2018
Centers for Disease Control and Prevention
Justification of Estimates for Appropriation Committees
Emerging and Zoonotic Infections (-$64.9 million)
The FY 2018 budget request reduces funding for Emerging and Zoonotic Infections by $64.9 million. At this level, CDC will eliminate Chronic Fatigue Syndrome and Prion Disease activities, and funding to support the on-going Antibiotic Resistance (AR) initiative is reduced.
Chronic Fatigue Syndrome (-$5.4 million)
The FY 2018 budget request eliminates funding for Chronic Fatigue Syndrome (CFS) activities. CFS affects between one and four million people in the United States. CDC’s CFS program works with states and experienced clinicians to develop tools to gather and analyze surveillance data and to educate clinicians and the public on the results of evidence-based studies. NIH has been funded to conduct biomedical research on CFS. In FY 2018, CFS activities are proposed for elimination, prioritizing funding to programs that support a broad range of diseases to maximize effectiveness in this limited-resource environment.
Eliminations
The FY 2018 budget request eliminates funding for CDC’s Chronic Fatigue Syndrome (CFS) and Prion Disease programs.
Chronic Fatigue Syndrome
CFS affects between one and four million people in the United States. CDC’s CFS program works with states and experienced clinicians to develop tools to gather and analyze surveillance data and to educate clinicians and the public on the results of evidence-based studies. NIH has been funded to conduct biomedical research on CFS. In FY 2018, CFS activities are proposed for elimination, prioritizing funding to programs that support a broad range of diseases to maximize effectiveness in this limited-resource environment.
Chronic Fatigue Syndrome (-$5.4 million)
The FY 2018 budget request eliminates funding for Chronic Fatigue Syndrome (CFS) activities. CFS affects between one and four million people in the United States. CDC’s CFS program works with states and experienced clinicians to develop tools to gather and analyze surveillance data and to educate clinicians and the public on the results of evidence-based studies. NIH has been funded to conduct biomedical research on CFS. In FY 2018, CFS activities are proposed for elimination, prioritizing funding to programs that support a broad range of diseases to maximize effectiveness in this limited-resource environment.
Chronic Fatigue Syndrome:
The Committee applauds the CDC’s efforts to collaborate with disease experts in its multi-site study. The Committee is pleased that the National Academy of Medicine [NAM] has clarified the disease definition and that the NAM and the CFS Advisory Committee have made recommendations to educate the medical community. The Committee encourages CDC to leverage those recommendations to provide new clinical guidelines and to execute a broad-based medical education campaign. To address the critical lack of access to clinical care, the Committee encourages CDC to work with the NIH and other agencies within the Department to find creative ways to support a clinical care component to regional Centers of Excellence. (Page 66)
CDC Response: Please see CDC’s FY 2018 budget narrative for response to this Significant Item.
Attachments
Last edited: